These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 1473073

  • 1. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.
    Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z.
    Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073
    [Abstract] [Full Text] [Related]

  • 2. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C.
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF, Rollet J.
    Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
    [Abstract] [Full Text] [Related]

  • 4. The long-term use of cyproterone acetate in pedophilia: a case study.
    Cooper AJ, Cernovsky Z, Magnus RV.
    J Sex Marital Ther; 1992 Jun; 18(4):292-302. PubMed ID: 1291700
    [Abstract] [Full Text] [Related]

  • 5. Leuprolide acetate suppresses pedophilic urges and arousability.
    Schober JM, Kuhn PJ, Kovacs PG, Earle JH, Byrne PM, Fries RA.
    Arch Sex Behav; 2005 Dec; 34(6):691-705. PubMed ID: 16362253
    [Abstract] [Full Text] [Related]

  • 6. The effects of cyproterone acetate on sleeping and waking penile erections in pedophiles: possible implications for treatment.
    Cooper AJ, Cernovovsky Z.
    Can J Psychiatry; 1992 Feb; 37(1):33-9. PubMed ID: 1532338
    [Abstract] [Full Text] [Related]

  • 7. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC, Jouannet P, Marson J, Soumah A.
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [Abstract] [Full Text] [Related]

  • 8. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [Abstract] [Full Text] [Related]

  • 9. Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.
    Moltz L, Römmler A, Post K, Schwartz U, Hammerstein J.
    Contraception; 1980 Apr; 21(4):393-413. PubMed ID: 6771095
    [Abstract] [Full Text] [Related]

  • 10. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
    Frick J, Bartsch G, Jakse G.
    Urol Res; 1977 Apr; 5(2):55-9. PubMed ID: 69351
    [Abstract] [Full Text] [Related]

  • 11. Use of low-dosage oral cyproterone acetate as a male contraceptive.
    Wang C, Yeung KK.
    Contraception; 1980 Mar; 21(3):245-72. PubMed ID: 6771091
    [Abstract] [Full Text] [Related]

  • 12. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [Abstract] [Full Text] [Related]

  • 13. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
    Bain J, Rachlis V, Robert E, Khait Z.
    Contraception; 1980 Apr; 21(4):365-79. PubMed ID: 6771093
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological interventions for those who have sexually offended or are at risk of offending.
    Khan O, Ferriter M, Huband N, Powney MJ, Dennis JA, Duggan C.
    Cochrane Database Syst Rev; 2015 Feb 18; 2015(2):CD007989. PubMed ID: 25692326
    [Abstract] [Full Text] [Related]

  • 15. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
    Meriggiola MC, Bremner WJ, Paulsen CA, Valdiserri A, Incorvaia L, Motta R, Pavani A, Capelli M, Flamigni C.
    J Clin Endocrinol Metab; 1996 Aug 18; 81(8):3018-23. PubMed ID: 8768868
    [Abstract] [Full Text] [Related]

  • 16. The effect of cyproterone acetate on serum testosterone, LH, FSH, and prolactin in male sexual offenders.
    Jeffcoate WJ, Matthews RW, Edwards CR, Field LH, Besser GM.
    Clin Endocrinol (Oxf); 1980 Aug 18; 13(2):189-95. PubMed ID: 6777092
    [Abstract] [Full Text] [Related]

  • 17. Comparison of cyproterone acetate (CPA) and leuprolide acetate (LHRH agonist) in a chronic pedophile: a clinical case study.
    Cooper AJ, Cernovsky ZZ.
    Biol Psychiatry; 1994 Aug 15; 36(4):269-71. PubMed ID: 7986892
    [No Abstract] [Full Text] [Related]

  • 18. Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias.
    Bradford JM, Pawlak A.
    Arch Sex Behav; 1993 Oct 15; 22(5):383-402. PubMed ID: 8239971
    [Abstract] [Full Text] [Related]

  • 19. The effects of exogenous testosterone on sexuality and mood of normal men.
    Anderson RA, Bancroft J, Wu FC.
    J Clin Endocrinol Metab; 1992 Dec 15; 75(6):1503-7. PubMed ID: 1464655
    [Abstract] [Full Text] [Related]

  • 20. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, Rivier J, Vale W, Swerdloff RS.
    J Clin Endocrinol Metab; 1992 Aug 15; 75(2):476-83. PubMed ID: 1639948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.